Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

Selected in the bioprocessing category, Dr. Narain is honored for his pioneering work at the intersection of biology, AI, and translational medicine. Under his leadership, BPGbio has focused on ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...